Webster Equity Partners inks $664m take-private of Lifecore Biomedical
Tuesday, September 29, 2026 · first reported by PE Hub and 1 other
Webster Equity Partners agreed to acquire Lifecore Biomedical (injectables CDMO) for up to $663.7M ($6.28/share cash + up to $160M CVRs); close expected Q4 2026.
- Also named
- Lifecore Biomedical
- Deal value
- $664M
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
2 sourcesMore in Deals
From the same day- New York Life boosts private credit arm with Invictus stakeAlternative Credit Investor +2
- Bain Capital-backed MRO Holdings agrees to 65 percent sale to AAR at $4bn EVPE Hub +1
- Veritas on course for Boycote takeover after CVC abandons bidPrivate Equity Wire
- Bridgepoint, Astorg weigh £2bn-plus sale of FenergoPrivate Equity Wire
- Parthenon Capital seals $200m sale of eSecLending to fintech CapitolisPE Hub +1
- Brixmor and Everview acquire Slate Grocery REIT in $2.3bn dealIPE Real Assets